Geode Capital Management, LLC X4 Pharmaceuticals, Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,447,512 shares of XFOR stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,447,512

Previous 3,515,538 1.94%

Holding current value

$1.24 Million

Previous $2.04 Million 13.24%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$0.54 - $0.86 $36,734 - $58,502	-68,026 Reduced 1.94%	3,447,512 $2.31 Million
Q2 2024 Aug 09, 2024	BUY	$0.58 - $1.47 $330,666 - $838,067	570,114 Added 19.36%	3,515,538 $2.04 Million
Q1 2024 May 13, 2024	BUY	$0.72 - $1.46 $102,942 - $208,743	142,975 Added 5.1%	2,945,424 $4.09 Million
Q4 2023 Feb 13, 2024	BUY	$0.61 - $0.99 $97,315 - $157,938	159,534 Added 6.04%	2,802,449 $2.35 Million
Q3 2023 Nov 13, 2023	BUY	$1.03 - $2.02 $301,486 - $591,264	292,705 Added 12.45%	2,642,915 $2.88 Million
Q2 2023 Aug 11, 2023	BUY	$0.82 - $2.49 $1.02 Million - $3.09 Million	1,241,526 Added 111.98%	2,350,210 $4.56 Million
Q1 2023 May 15, 2023	BUY	$0.8 - $1.22 $416,934 - $635,824	521,168 Added 88.71%	1,108,684 $964,000
Q4 2022 Feb 13, 2023	BUY	$0.69 - $2.21 $64,762 - $207,428	93,859 Added 19.01%	587,516 $583,000
Q3 2022 Nov 14, 2022	BUY	$0.89 - $1.71 $270,657 - $520,026	304,109 Added 160.44%	493,657 $844,000
Q2 2022 Aug 12, 2022	BUY	$0.88 - $1.91 $5,518 - $11,977	6,271 Added 3.42%	189,548 $182,000
Q1 2022 May 13, 2022	BUY	$1.48 - $2.58 $7,721 - $13,459	5,217 Added 2.93%	183,277 $320,000
Q3 2021 Nov 12, 2021	BUY	$4.53 - $6.45 $73,127 - $104,122	16,143 Added 9.97%	178,060 $941,000
Q2 2021 Aug 13, 2021	SELL	$6.49 - $9.56 $624,649 - $920,130	-96,248 Reduced 37.28%	161,917 $1.05 Million
Q1 2021 May 12, 2021	BUY	$6.63 - $10.28 $11,343 - $17,589	1,711 Added 0.67%	258,165 $2.22 Million
Q4 2020 Feb 12, 2021	BUY	$5.41 - $7.4 $72,851 - $99,648	13,466 Added 5.54%	256,454 $1.65 Million
Q3 2020 Nov 13, 2020	BUY	$6.09 - $9.15 $91,447 - $137,396	15,016 Added 6.59%	242,988 $1.65 Million
Q2 2020 Aug 13, 2020	BUY	$7.98 - $10.44 $148,052 - $193,693	18,553 Added 8.86%	227,972 $2.12 Million
Q1 2020 May 14, 2020	BUY	$6.03 - $11.01 $171,842 - $313,762	28,498 Added 15.75%	209,419 $2.09 Million
Q4 2019 Feb 13, 2020	BUY	$9.93 - $14.33 $659,242 - $951,354	66,389 Added 57.97%	180,921 $1.94 Million
Q3 2019 Nov 12, 2019	BUY	$11.06 - $15.75 $4,988 - $7,103	451 Added 0.4%	114,532 $1.46 Million
Q2 2019 Aug 14, 2019	BUY	$12.57 - $21.67 $1.27 Million - $2.19 Million	101,179 Added 784.21%	114,081 $1.71 Million
Q1 2019 May 14, 2019	BUY	$15.19 - $22.98 $195,981 - $296,487	12,902 New	12,902 $224,000

Others Institutions Holding XFOR

# of Institutions

104

Shares Held

100M

Call Options Held

213K

Put Options Held

50.6K

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $24.7M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC X4 Pharmaceuticals, Inc Transaction History